Covid-19 Response

Barry Gardiner Excerpts

Tuesday 2nd June 2020 Commons Chamber

[Matt Hancock]

That is an incredibly important point, because the backlog has of course built up as we had to protect the NHS in the heat of the crisis. The independent sector has played a critical role in helping us get through the crisis and will play a critical role in future. That has put to bed any lingering, outdated arguments about a split between public and private in healthcare. What matters is the healthcare that people get. We could not have got through the crisis without the combined teamwork of the public and private sectors.

[Barry Gardiner (Brent North) (Lab)]

Professor Newton spoke today of the vital importance of increasing serology to tackle the virus. Capillary blood from fingerprick tests has long been used to test and control viruses, from measles to dengue fever. Will the Secretary of State therefore explain why the Medicines and Healthcare Products Regulatory Agency guidance asks providers of fingerprick tests to stop offering the service? Can he point to any published scientific data that suggests a clinical difference between capillary and venous blood? If not, why is he blocking the serology roll-out that Professor Newton considers so important?

[Matt Hancock]

First, serology tests are very important, and I am glad we are now doing over 40,000 a day. Given that they first got approval only two weeks ago, that has been a fantastic effort by the NHS and social care to get the roll-out going out so quickly. Secondly, fingerprick tests would be a big step forward. We are currently assessing the clinical validity of a number of fingerprick tests, because a bad test is worse than no test at all. I am sure the hon. Gentleman will agree with that.